Biologic Medicines: The Biggest Driver Of Rising Drug Prices

Australia News News

Biologic Medicines: The Biggest Driver Of Rising Drug Prices
Australia Latest News,Australia Headlines
  • 📰 Forbes
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 53%

In 2017, biologic drugs represented 2 percent of all U.S. prescriptions, but 37 percent of net drug spending. Since 2014, biologic drugs account for nearly all of the growth in net drug spending. Why is that?

, the U.S. has the most efficient market in the world—by a healthy margin—for unbranded, small molecule, generic drugs. Today, 90 percent of all U.S. prescriptions are for generic drugs: the highest share in the world.

In the early 2000s, one of Johnson & Johnson’s versions of Amgen’s Epogen—called Eprex—was leading to reported cases of pure red cell aplasia, or PRCA. A new version of Eprex was causing a handful of patients to develop antibodies to Eprex. But that wasn’t the end of the story. In these rare cases, antibodies to Eprex also digested a patient’s indigenously produced erythropoietin.

The BPCIA was intended by its authors to provide regulatory clarity around biosimilars, something that had been stifling the biosimilars industry up to that point. But because the BPCIA was part of Obamacare, Obamacare-related politics affected the way in which the law was designed.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Forbes /  🏆 394. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eli Lilly offers half-price insulin as politicians pressure it over drug costsEli Lilly offers half-price insulin as politicians pressure it over drug costsDrug maker Eli Lilly & Co. will offer a half-price version of its blockbuster insulin, becoming one of the first companies to effectively cut the price of a top-selling drug amid the ongoing U.S. debate over pharmaceutical costs.
Read more »

Eli Lilly seeks to quell drug price anger with cheaper insulinEli Lilly seeks to quell drug price anger with cheaper insulinDrugmaker Eli Lilly announced plans on Monday to sell a half-price version of it...
Read more »

Tesla backtracks on store closures, plans top-end price riseTesla backtracks on store closures, plans top-end price riseElectric carmaker Tesla Inc backed off its plan to close all of its U.S. stores ...
Read more »

The rise, set and rise of Daylight Saving TimeThe rise, set and rise of Daylight Saving TimeThe first “spring forward” in the United States was so maligned, Congress overrode the president to get rid of it.
Read more »

How Machine Learning Is Crafting Precision MedicineHow Machine Learning Is Crafting Precision MedicineMedicine has become more and more individualized since the days. Today, new technologies are revitalizing the promise paid intel
Read more »

A Doctor’s Prescription for More AI in MedicineA Doctor’s Prescription for More AI in MedicineCan artificial intelligence improve the accuracy of a doctor’s diagnosis and even bring more compassion to medicine?
Read more »

Breakingviews - Mizuho’s harsh medicine gives taste of Japan illsBreakingviews - Mizuho’s harsh medicine gives taste of Japan illsOn Breakingviews – Mizuho’s harsh medicine gives taste of Japan ills, says petesweeneypro:
Read more »

Mizuho’s harsh medicine gives taste of Japan illsMizuho’s harsh medicine gives taste of Japan illsThe country’s second-biggest bank took a $6 bln hit and slashed its annual profit forecast by 86 pct. Losses on dozy rural branches and duff offshore trades are symptomatic of ultra-loose monetary policy. New rules to ease consolidation should at least offer some partial relief.
Read more »

Analysis | The Health 202: One GOP senator is urging the drug industry to make good on lowering pricesAnalysis | The Health 202: One GOP senator is urging the drug industry to make good on lowering pricesThe Health 202: One GOP senator is urging the drug industry to make good on lowering prices
Read more »



Render Time: 2025-03-06 20:45:20